bioAffinity Technologies, Inc. (BIAF) vs Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
A side-by-side comparison of bioAffinity Technologies, Inc. and Shuttle Pharmaceuticals Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIAF
bioAffinity Technologies, Inc.
$6.07HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$4.17HealthcareDelayed quote: Oct 6, 2026, 2:53 PM EDT
Total return — BIAF vs SHPH
growth of $100 · dividends reinvested · last 4yBIAF -99.8% (-79.8%/yr)SHPH -100.0% (-91.5%/yr)BIAF compounded faster over this window
Log scale — wide-divergence pair
BIAF SHPH
BIAF vs SHPH: by the numbers
- •BIAF is the larger company ($3M vs $2M market cap).
- •Both run net losses; SHPH's is the smaller (0.00% vs -257.33% net margin).
Metrics side by side
Valuation
| Metric | BIAF | SHPH |
|---|---|---|
| P/S ratio | 0.43 | N/A |
| P/B ratio | 0.67 | 0.13 |
Profitability
| Metric | BIAF | SHPH |
|---|---|---|
| Gross margin | 23.21% | 0.00% |
| Operating margin | -171.58% | 0.00% |
| Net margin | -257.33% | 0.00% |
| ROE | -402.92% | -53.49% |
| ROIC | -237.93% | -58.05% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.